Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA “de novo” approval
MYOCENE kicks off the first FDA De Novo clearance of 2025 for its groundbreaking muscle fatigue monitoring device. LIèGE, LIèGE, BELGIUM, January 30, 2025 /EINPresswire.com/ -- Myocene, the Belgian sportstech company specializing in innovative …